Public Reporting

ACO Name and Location
Rio Grande Valley Health Alliance, LLC
Previous Names: N/A
200 S. 10th Street, Suite 407
McAllen, TX 78501
ACO Primary Contact

Primary Contact Name Victoria Farias
Primary Contact Phone Number (956) 627-4602
Primary Contact Email Address vfarias@rgvha.org

 
Organizational Information
ACO participants:

ACO Participants ACO Participant in Joint Venture (Enter Y or N)
Alfredo V. Gonzalez, M.D., P.A. N
Mid Valley Family Practice Associates, P.A. N
Sobia Nasir MD PA N
Mario R. Anzaldua MD PA N
Alfredo Lopez, Jr., M.D., P.A. N
Alcides N. Amador, MD N
Manuel J Mercado Md Pa N
Rene Vela M.D., P.A. N
Luis Delgado, Jr., M.D., P.A. N
Palm Valley Medical Clinic, P.A. N
La Joya”s Neighborhood Doctor, P.A. N
Maximiliano Hernandez, MDPA N
Dona E. Cooper-Dockery, M.D., P.A. N
Oscar Benavides M.D. P.A. N
Socrates A. Garrigos M.D. P.A. N
Mission Adult and Senior Care Center, PA N
Sathiyaraj George Md Pa N
Javier A. Saenz, M.D., P.A. N
Marco A Gutierrez Md And Associates N
Samuel Garcia Jr. MD PLLC N

 

 

ACO governing body:

Member Member’s Voting Power – Expressed as a percentage or number Membership Type ACO Participant Legal Business Name/DBA, if Applicable
Last Name First Name Title/Position
Delgado Luis President 12.5% Voting Member Luis Delgado, Jr., M.D., P.A.
Garcia Samuel Vice-President 12.5% Voting Member Samuel Garcia Jr. MD PLLC
Fuentes Alejandro Secretary 12.5% Voting Member Mid Valley Family Practice Associates, P.A.
Saenz Javier Treasurer 12.5% Voting Member Javier A. Saenz, M.D., P.A.
Anzaldua Mario Medical Director 12.5% Voting Member Mario R. Anzaldua MD PA
Heredia Roger Board Member 12.5% Voting Member Mid Valley Family Practice Associates, P.A.
Mery Donna Compliance Officer 12.5% Voting Member Mid Valley Family Practice Associates, P.A.
Espinosa Juan Medicare Beneficiary Representative 12.5% Voting Member

 

Key ACO clinical and administrative leadership:

Victoria Farias ACO Executive
Mario Anzaldua Medical Director
Donna Mery Compliance Officer
Alfredo Lopez, Jr. Quality Assurance/Improvement Officer

 

 

Associated committees and committee leadership:

Committee Name Committee Leader Name and Position
Executive Committee Luis Delgado, Jr., M.D., Chair
Clinical Best Practices Committee Mario Anzaldua, M.D., Chair
Finance Committee Javier A. Saenz, M.D., Chair
Health Information and Data Committee Norma Cavazos-Salas, M.D. Chair
Compliance Committee Donna Mery, M.D. Chair
Quality Improvement and Assurance Committee Alfredo Lopez, Jr., M.D., Chair

 

Types of ACO participants, or combinations of participants, that formed the ACO:

  • Networks of individual practices of ACO professionals

 
Shared Savings and Losses
Amount of Shared Savings/Losses

  • Second Agreement Period
    • Performance Year 2017, $6,844,479
    • Performance Year 2016, $6,175,625
  • First Agreement Period
    • Performance Year 2015, $6,947,600
    • Performance Year 2014, $3,403,175
    • Performance Year 2013, $2,945,246

 

Shared Savings Distribution

  • Second Agreement Period
    • Performance Year 2017
      • Proportion invested in infrastructure: 15%
      • Proportion invested in redesigned care processes/resources:  5%
      • Proportion of distribution to ACO participants: 80%
    • Performance Year 2016
      • Proportion invested in infrastructure: 15%
      • Proportion invested in redesigned care processes/resources: 5%
      • Proportion of distribution to ACO participants: 80%
  • First Agreement Period
    • Performance Year 2015
      • Proportion invested in infrastructure: 15%
      • Proportion invested in redesigned care processes/resources: 5%
      • Proportion of distribution to ACO participants: 80%
    • Performance Year 2014
      • Proportion invested in infrastructure: 15%
      • Proportion invested in redesigned care processes/resources: 5%
      • Proportion of distribution to ACO participants: 80%
    • Performance Year 2013
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A

Quality Performance Results
2017 Quality Performance Results:

ACO# Measure Name Rate ACO Mean
ACO-1 CAHPS: Getting Timely Care, Appointments, and Information 77.35 80.60
ACO-2 CAHPS: How Well Your Providers Communicate 91.82 93.13
ACO-3 CAHPS: Patients’ Rating of Provider 91.83 92.31
ACO-4 CAHPS: Access to Specialists 86.32 83.32
ACO-5 CAHPS: Health Promotion and Education 62.02 62.30
ACO-6 CAHPS: Shared Decision Making 77.30 75.85
ACO-7 CAHPS: Health Status/Functional Status 68.10 73.05
ACO-34 CAHPS: Stewardship of Patient Resources 28.41 25.68
ACO-8 Risk Standardized, All Condition Readmission 15.14 15.01
ACO-35 Skilled Nursing Facility 30-day All-Cause Readmission measure (SNFRM) 18.09 18.46
ACO-36 All-Cause Unplanned Admissions for Patients with Diabetes 54.39 53.95
ACO-37 All-Cause Unplanned Admissions for Patients with Heart Failure 77.87 79.16
ACO-38 All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions 59.13 61.74
ACO-43 Ambulatory Sensitive Condition Acute Composite (AHRQ* Prevention Quality Indicator (PQI #91)) 1.75 1.93
ACO-11 Use of Certified EHR Technology 100.00 98.48
ACO-12 Medication Reconciliation 94.40 75.32
ACO-13 Falls: Screening for Future Fall Risk 97.43 74.38
ACO-44 Imaging Studies for Low Back Pain 76.00 67.32
ACO-14 Preventive Care and Screening: Influenza Immunization 92.59 72.52
ACO-15 Pneumonia Vaccination Status for Older Adults 88.18 72.92
ACO-16 Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up 91.58 70.69
ACO-17 Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention 100.00 90.48
ACO-18 Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan 91.09 61.98
ACO-19 Colorectal Cancer Screening 88.04 64.58
ACO-20 Breast Cancer Screening 84.00 70.05
ACO-42 Statin Therapy for the Prevention and Treatment of Cardiovascular Disease 91.32 79.89
ACO-27 Diabetes Mellitus: Hemoglobin A1c Poor Control 18.15 16.74
ACO-41 Diabetes: Eye Exam 80.69 50.37
ACO-28 Hypertension (HTN): Controlling High Blood Pressure 84.05 71.47
ACO-30 Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic 95.58 86.86

 

Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low samples.

 

Note: In the Quality Performance Results file(s) above, search for “Rio Grande Valley Health Alliance, LLC” to view the quality performance results. This ACO can also be found by using the ACO ID A94912 in the public use files on data.cms.gov.
Payment Rule Waivers

  • Yes, our ACO does use the SNF 3-Day Rule Waiver.

 

© 2019 Rio Grande Valley Health Alliance. All rights reserved.
Website Designed by Imagine It Studios